Literature DB >> 21619519

Metabolism of ginseng and its interactions with drugs.

Lian-Wen Qi1, Chong-Zhi Wang, Guang-Jian Du, Zhi-Yu Zhang, Tyler Calway, Chun-Su Yuan.   

Abstract

Ginseng is an herbal medicine used worldwide. It is reported to have a wide range of pharmacological activities because of a diversified group of steroidal saponins called ginsenosides. Compared to extensive pharmacological studies of ginseng, the pharmacokinetics, especially the metabolism of this herb, has received less attention. In this article we review the known pharmacokinetic data on ginseng. Understanding ginseng's pharmacokinetics may reduce the potential for interactions in patients who use both ginseng and prescription medications. In addition, bioavailability after taking ginseng orally is low, and the metabolites of ginsenosides produced by gut microbiota may be biologically active. One ginseng metabolite, Compound K, and its potential for cancer chemoprevention is also discussed. An active ginseng metabolite may differ in distribution and clearance from its parent compound, and the parent compound and its metabolite may be bioactive by similar or different mechanisms. Thus, further investigation of ginseng metabolites is needed for predicting the therapeutic outcome with ginseng.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21619519      PMCID: PMC3291795          DOI: 10.2174/138920011797470128

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  64 in total

Review 1.  Panax ginseng--a non-organ-specific cancer preventive?

Authors:  T K Yun
Journal:  Lancet Oncol       Date:  2001-01       Impact factor: 41.316

2.  Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans.

Authors:  Bill J Gurley; Stephanie F Gardner; Martha A Hubbard; D Keith Williams; W Brooks Gentry; Yanyan Cui; Catharina Y W Ang
Journal:  Clin Pharmacol Ther       Date:  2002-09       Impact factor: 6.875

3.  Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats.

Authors:  Qing Fang Xu; Xiao Ling Fang; Dao Feng Chen
Journal:  J Ethnopharmacol       Date:  2003-02       Impact factor: 4.360

4.  Degradation of ginsenosides in humans after oral administration.

Authors:  Mona Abdel Tawab; Ute Bahr; Michael Karas; Mario Wurglics; Manfred Schubert-Zsilavecz
Journal:  Drug Metab Dispos       Date:  2003-08       Impact factor: 3.922

5.  A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage.

Authors:  Seon-Hee Oh; Byung-Hoon Lee
Journal:  Toxicol Appl Pharmacol       Date:  2004-02-01       Impact factor: 4.219

6.  Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial.

Authors:  Chun-Su Yuan; Gang Wei; Lucy Dey; Theodore Karrison; Linda Nahlik; Spring Maleckar; Kristen Kasza; Michael Ang-Lee; Jonathan Moss
Journal:  Ann Intern Med       Date:  2004-07-06       Impact factor: 25.391

7.  Antiplatelet actions of panaxynol and ginsenosides isolated from ginseng.

Authors:  C M Teng; S C Kuo; F N Ko; J C Lee; L G Lee; S C Chen; T F Huang
Journal:  Biochim Biophys Acta       Date:  1989-03-24

8.  Role of the Fas/Fas ligand death receptor pathway in ginseng saponin metabolite-induced apoptosis in HepG2 cells.

Authors:  Seon-Hee Oh; Hu-Quan Yin; Byung-Hoon Lee
Journal:  Arch Pharm Res       Date:  2004-04       Impact factor: 4.946

Review 9.  Proof of the mysterious efficacy of ginseng: basic and clinical trials: metabolic activation of ginsenoside: deglycosylation by intestinal bacteria and esterification with fatty acid.

Authors:  Hideo Hasegawa
Journal:  J Pharmacol Sci       Date:  2004-06       Impact factor: 3.337

10.  American ginseng. III. Pharmacokinetics of ginsenosides in the rabbit.

Authors:  S E Chen; R J Sawchuk; E J Staba
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1980       Impact factor: 2.441

View more
  28 in total

1.  An unwanted complement: Rare case of potential liver injury induced by an interaction between ginseng and atorvastatin.

Authors:  Robyn Laube; Ken Liu
Journal:  Br J Clin Pharmacol       Date:  2019-04-13       Impact factor: 4.335

Review 2.  Pharmacokinetic Drug Interactions with Panax ginseng.

Authors:  Meenakshi R Ramanathan; Scott R Penzak
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-08       Impact factor: 2.441

Review 3.  Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress- and aging-related diseases.

Authors:  Alexander G Panossian; Thomas Efferth; Alexander N Shikov; Olga N Pozharitskaya; Kenny Kuchta; Pulok K Mukherjee; Subhadip Banerjee; Michael Heinrich; Wanying Wu; De-An Guo; Hildebert Wagner
Journal:  Med Res Rev       Date:  2020-10-25       Impact factor: 12.944

4.  Effect of Panax ginseng on Carbamazepine Pharmacokinetics in Rabbits.

Authors:  Issam Mohammed Abushammala; Fatma Khaled El-Shaikh Ali; Kamal Fakher Abu Shammaleh; Mohammed Mahmoud Taha; Mohammed Yousef Miqdad
Journal:  Turk J Pharm Sci       Date:  2021-02-25

5.  Network-based drug discovery by integrating systems biology and computational technologies.

Authors:  Elaine L Leung; Zhi-Wei Cao; Zhi-Hong Jiang; Hua Zhou; Liang Liu
Journal:  Brief Bioinform       Date:  2012-08-09       Impact factor: 11.622

6.  Compound K, a Ginsenoside Metabolite, Inhibits Colon Cancer Growth via Multiple Pathways Including p53-p21 Interactions.

Authors:  Zhiyu Zhang; Guang-Jian Du; Chong-Zhi Wang; Xiao-Dong Wen; Tyler Calway; Zejuan Li; Tong-Chuan He; Wei Du; Marc Bissonnette; Mark W Musch; Eugene B Chang; Chun-Su Yuan
Journal:  Int J Mol Sci       Date:  2013-01-31       Impact factor: 5.923

Review 7.  Pharmacological effects of ginseng on infectious diseases.

Authors:  Nguyen H Nguyen; Cuong Thach Nguyen
Journal:  Inflammopharmacology       Date:  2019-08-12       Impact factor: 5.093

Review 8.  Role of gut microbiota in identification of novel TCM-derived active metabolites.

Authors:  Tzu-Lung Lin; Chia-Chen Lu; Wei-Fan Lai; Ting-Shu Wu; Jang-Jih Lu; Young-Mao Chen; Chi-Meng Tzeng; Hong-Tao Liu; Hong Wei; Hsin-Chih Lai
Journal:  Protein Cell       Date:  2020-09-15       Impact factor: 14.870

9.  Identification and confirmation of 14-3-3 ζ as a novel target of ginsenosides in brain tissues.

Authors:  Feiyan Chen; Lin Chen; Weifeng Liang; Zhengguang Zhang; Jiao Li; Wan Zheng; Zhu Zhu; Jiapeng Zhu; Yunan Zhao
Journal:  J Ginseng Res       Date:  2020-12-29       Impact factor: 6.060

Review 10.  Cytochrome P450 enzyme mediated herbal drug interactions (Part 2).

Authors:  Sompon Wanwimolruk; Kamonrat Phopin; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2014-08-20       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.